Log in to save to my catalogue

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of u...

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of u...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pnas_primary_107_32_14351

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo

About this item

Full title

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (32), p.14351-14356

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

A high plasma urate concentration (PUA), related to loss of urate oxidase in evolution, is postulated to protect humans from oxidative injury. This hypothesis has broad clinical relevance, but support rests largely on in vitro data and epidemiologic associations. Pegloticase therapy generates H₂O₂ while depleting urate, offering an in vivo test of...

Alternative Titles

Full title

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pnas_primary_107_32_14351

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pnas_primary_107_32_14351

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1001072107

How to access this item